FAM
REGN icon

Formidable Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Formidable Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$528K Hold
847
– – 0.08% 226
2026
Q1 		$654K Sell
847
-30
-3% -$23K 0.1% 187
2025
Q4 		$677K Sell
877
-200
-19% -$136K 0.1% 199
2025
Q3 		$606K Hold
1,077
– – 0.1% 203
2025
Q2 		$565K Buy
1,077
+161
+18% +$89.9K 0.09% 212
2025
Q1 		$581K Sell
916
-3
-0.3% -$2.06K 0.1% 204
2024
Q4 		$655K Buy
919
+131
+17% +$110K 0.11% 184
2024
Q3 		$828K Sell
788
-38
-5% -$42.3K 0.13% 150
2024
Q2 		$868K Sell
826
-49
-6% -$47.5K 0.14% 141
2024
Q1 		$842K Buy
875
+91
+12% +$86.5K 0.14% 152
2023
Q4 		$689K Sell
784
-19
-2% -$15.6K 0.14% 140
2023
Q3 		$661K Sell
803
-300
-27% -$236K 0.15% 145
2023
Q2 		$793K Buy
1,103
+184
+20% +$142K 0.17% 114
2023
Q1 		$755K Sell
919
-904
-50% -$682K 0.16% 114
2022
Q4 		$1.31M Hold
1,823
– – 0.3% 63
2022
Q3 		$1.25M Buy
1,823
+43
+2% +$27.1K 0.29% 65
2022
Q2 		$1.05M Buy
1,780
+212
+14% +$138K 0.24% 81
2022
Q1 		$1.09M Buy
1,568
+98
+7% +$62K 0.21% 90
2021
Q4 		$928K Buy
1,470
+147
+11% +$90.4K 0.18% 112
2021
Q3 		$801K Buy
+1,323
New +$821K 0.15% 129

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Formidable Asset Management's REGN Position: Q2 2026 in Review

Formidable Asset Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 847 shares worth $528K. The position accounts for 0.08% of the portfolio, ranked #226.

Formidable Asset Management first reported a position in REGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.31M in Q4 2022. 237 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Formidable Asset Management held 847 shares of Regeneron Pharmaceuticals worth $528K as of Q2 2026.
  • Formidable Asset Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.08% of Formidable Asset Management's portfolio in Q2 2026, its #226 holding.
  • Formidable Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • Formidable Asset Management's Regeneron Pharmaceuticals position peaked at $1.31M in Q4 2022.
  • 237 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.